Related references
Note: Only part of the references are listed.Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR
Scott H. Donaldson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Correctors of the Major Cystic Fibrosis Mutant Interact through Membrane-Spanning Domains
Onofrio Laselva et al.
MOLECULAR PHARMACOLOGY (2018)
Corrector combination therapies for F508de1-CFTR
John W. Hanrahan et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Combination of Correctors Rescues CFTR Transmembrane-Domain Mutants by Mitigating their Interactions with Proteostasis
Miqueias Lopes-Pacheco et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies
Daniel Martinez Molina et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
The investigational Cystic Fibrosis drug Trimethylangelicin directly modulates CFTR by stabilizing the first membrane-spanning domain
Onofrio Laselva et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX-770 (ivacaftor)
Elizabeth Matthes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids
Johanna F. Dekkers et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
Gudio Veit et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil
Helena Almqvist et al.
NATURE COMMUNICATIONS (2016)
Latonduine Analogs Restore F508del-Cystic Fibrosis Transmembrane Conductance Regulator Trafficking through the Modulation of Poly-ADP Ribose Polymerase 3 and Poly-ADP Ribose Polymerase 16 Activity
Graeme W. Carlile et al.
MOLECULAR PHARMACOLOGY (2016)
Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking
Graeme W. Carlile et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Restoration of NBD1 Thermal Stability Is Necessary and Sufficient to Correct ΔF508 CFTR Folding and Assembly
Lihua He et al.
JOURNAL OF MOLECULAR BIOLOGY (2015)
Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR
Zhe Xu et al.
JOURNAL OF PHYSIOLOGY-LONDON (2014)
Searching for Combinations of Small-Molecule Correctors to Restore F508del-Cystic Fibrosis Transmembrane Conductance Regulator Function and Processing
Clement Boinot et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Synergy-Based Small-Molecule Screen Using a Human Lung Epithelial Cell Line Yields ΔF508-CFTR Correctors That Augment VX-809 Maximal Efficacy
Puay-Wah Phuan et al.
MOLECULAR PHARMACOLOGY (2014)
Corrector VX-809 stabilizes the first transmembrane domain of CFTR
Tip W. Loo et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Revertants, Low Temperature, and Correctors Reveal the Mechanism of F508del-CFTR Rescue by VX-809 and Suggest Multiple Agents for Full Correction
Carlos M. Farinha et al.
CHEMISTRY & BIOLOGY (2013)
VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1
Hong Yu Ren et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
Mechanism-based corrector combination restores ΔF508-CFTR folding and function
Tsukasa Okiyoneda et al.
NATURE CHEMICAL BIOLOGY (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
Novel pharmacological strategies to treat cystic fibrosis
John W. Hanrahan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Protein Folding in the Endoplasmic Reticulum
Ineke Braakman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences
Juan L. Mendoza et al.
CELL (2012)
Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function
Wael M. Rabeh et al.
CELL (2012)
Correction of F508del-CFTR Trafficking by the Sponge Alkaloid Latonduine Is Modulated by Interaction with PARP
Graeme W. Carlile et al.
CHEMISTRY & BIOLOGY (2012)
Conformational Changes Relevant to Channel Activity and Folding within the first Nucleotide Binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator
Rhea P. Hudson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
J. P. Clancy et al.
THORAX (2012)
Identification of a NBD1-Binding Pharmacological Chaperone that Corrects the Trafficking Defect of F508del-CFTR
Heidi M. Sampson et al.
CHEMISTRY & BIOLOGY (2011)
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Fredrick Van Goor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Influence of cell background on pharmacological rescue of mutant CFTR
Nicoletta Pedemonte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Emerging therapies for cystic fibrosis lung disease
Hartmut Grasemann et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine
Renaud Robert et al.
MOLECULAR PHARMACOLOGY (2010)
Trafficking of immature ΔF508-CFTR to the plasma membrane and its detection by biotinylation
Yishan Luo et al.
BIOCHEMICAL JOURNAL (2009)
Cooperative Assembly and Misfolding of CFTR Domains In Vivo
Kai Du et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
CFTR Delivery to 25% of Surface Epithelial Cells Restores Normal Rates of Mucus Transport to Human Cystic Fibrosis Airway Epithelium
Liqun Zhang et al.
PLOS BIOLOGY (2009)
Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect
Renaud Robert et al.
MOLECULAR PHARMACOLOGY (2008)
Processing and function of CFTR-ΔF508 are species-dependent
Lynda S. Ostedgaard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Correctors of protein trafficking defects identified by a novel high-throughput screening assay
Graeme W. Carlile et al.
CHEMBIOCHEM (2007)
Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination
Masoud Vedadi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules
F Van Goor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
The ABC protein turned chloride channel whose failure causes cystic fibrosis
DC Gadsby et al.
NATURE (2006)
Gene transfer of CFTR to airway epithelia:: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR
SL Farmen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening
N Pedemonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator
HA Lewis et al.
EMBO JOURNAL (2004)
Share Paper
